Lyophilized Drugs Market Witnesses High Growth Owing to Rising Need for Long Shelf-Life Drugs
Lyophilized Drugs Market The Lyophilized Drugs Market comprises drugs that have undergone lyophilization or freeze-drying, a process that converts the drug from a liquid to a solid state via drying under partial vacuum. Some key advantages of lyophilization include improved stability at room temperature, ease of storage and transport, and long shelf life without refrigeration up to two years. The rising need for long shelf-life and temperature-stable drugs across various therapeutic areas such as oncology, infectious disease, and autoimmune disorders is driving significant demand for lyophilized drugs. The global Lyophilized Drugs Market is estimated to be valued at US$ 366.11 million in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period from 2024 to 2030. Key Takeaways Key players operating in the lyophilized drugs are BASF SE, Evonik Industries AG, Clariant AG, DuPont de Nemours, Inc., Albemarle Corporation, Arkema SA, Johnson Matthey PLC, Mitsubishi Chemica